At Tilak Healthcare, we create a digital solution that combines clinically validated medical tests with a gaming experience to enhance patient engagement.
Our vision
Visual impairments affect 2.2 billion people worldwide with chronic macular diseases being the leading cause of blindness.
Our vision is to transform the way chronic eye conditions are managed by empowering patients at home while reinforcing the link with their physicians to optimize treatments.
Tilak Healthcare was founded in 2016 by Edouard Gasser (ex-Gameloft) and Pr José-Alain Sahel, recognized internationally for his work in retinal diseases, founder of the Institut de la Vision in France and Director of the Department of Ophthalmology at the University of Pittsburgh School of Medicine.
Together, they believed that the time people spent playing mobile games like "candy crush" could be put to better use. That's how they got the idea of OdySight, a medical mobile app that patients would enjoy using as much as they need to.
Our product
OdySight®
OdySight® is a medical mobile app available with a prescription by an ophthalmologist and recommended for monitoring vision parameters of patients suffering from chronic maculopathies. It serves as an important link in building patient-physician relationships and plays an important role in optimizing treatments.
Learn more
OdySight®
OdySight® is a medical mobile app available with a prescription by an ophthalmologist and recommended for monitoring vision parameters of patients suffering from chronic maculopathies. It serves as an important link in building patient-physician relationships and plays an important role in optimizing treatments.
Learn more
OdySight®
OdySight® is a medical mobile app available with a prescription by an ophthalmologist and recommended for monitoring vision parameters of patients suffering from chronic maculopathies. It serves as an important link in building patient-physician relationships and plays an important role in optimizing treatments.
Learn more
OdySight®
OdySight® is a medical mobile app available with a prescription by an ophthalmologist and recommended for monitoring vision parameters of patients suffering from chronic maculopathies. It serves as an important link in building patient-physician relationships and plays an important role in optimizing treatments.
Tilak Healthcare has announced a framework agreement with Novartis Pharma AG for the promotion internationally of Tilak Healthcare's first clinically validated mobile app for patient remote vision monitoring, OdySight®.
Digital tools for remote monitoring have revolutionized the current landscape of healthcare delivery. With the advent of smartphones and tablets, the development of mobile medical applications (apps) has created a new dimension in telemedicine.
Tilak Healthcare, a video game studio specializing in mobile medical games for patients with chronic diseases, announced an exclusive co-promotion partnership with Novartis France for OdySight®, its first clinically validated mobile game to monitor vision remotely.
French startup Tilak Healthcare, which is developing video games intended to diagnose and follow-up with chronic diseases, has raised $2.7 million (2.5 million euros) from the iBionext Growth Fund.